FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19866411000001102: Bonviva 150mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Feb 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67071601000001119 Bonviva 150mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67071701000001112 Bonviva 150mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bonviva 150mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Is a Ibandronic acid 150mg tablets true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has active ingredient Ibandronic acid true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has specific active ingredient Ibandronic sodium monohydrate false Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Is a Bonviva true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Bonviva 150mg tablets (Lexon (UK) Ltd) Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bonviva 150mg tablets (Lexon (UK) Ltd) 1 tablet Has AMP True Bonviva 150mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start